Advertisement

Topics

CHMP grant positive opinion to ixazomib for conditional approval against MM

07:20 EDT 23 Sep 2016 | ecancermedicalscience

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending the conditional approval of ixazomib capsules in combination with lenalidomide and dexamethasone for the treatment...

Original Article: CHMP grant positive opinion to ixazomib for conditional approval against MM

NEXT ARTICLE

More From BioPortfolio on "CHMP grant positive opinion to ixazomib for conditional approval against MM"

Quick Search
Advertisement